Showing results (781-790 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|September 10, 2022
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studiesHelen S Marshall, Timo Vesikari, Peter C Richmond, et al.
The Lancet. Infectious Diseases|January 20, 2022
Fluid therapy for severe malariaLaura C Kalkman, Thomas Hänscheid, Sanjeev Krishna, et al.
The Lancet. Infectious Diseases|November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trialPeter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
The Lancet. Infectious Diseases|November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
The Lancet. Infectious Diseases|October 23, 2022
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trialDaniela Manno, Agnes Bangura, Frank Baiden, et al.
The Lancet. Infectious Diseases|October 23, 2022
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trialShabir A Madhi, Gaurav Kwatra, Simone I Richardson, et al.
The Lancet. Infectious Diseases|October 1, 2022
Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil: a spatiotemporal modelling studyGabriel Ribeiro Dos Santos, Betina Durovni, Valeria Saraceni, et al.
The Lancet. Infectious Diseases|February 20, 2021
BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trialSarah Prentice, Beatrice Nassanga, Emily L Webb, et al.
The Lancet. Infectious Diseases|March 7, 2021
Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trialEric P F Chow, Deborah A Williamson, Jane S Hocking, et al.
The Lancet. Infectious Diseases|August 28, 2022
Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo)Jeremy Werner Deuel, Elisa Lauria, Thibault Lovey, et al.
Pageof 270